NCT03751943View on ClinicalTrials.gov

NanoFUSE® PL Gutter PMCF

PHASE4UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Degenerative Disc Disease
Interventions
DEVICE

NanoFUSE® Bioactive Matrix (75%) w/autograft (25%)

NanoFUSE® Bioactive Matrix (75%) w/autograft (25%)within one posterolateral gutter

Sponsors
All Listed Sponsors
lead

NanoFUSE Biologics, LLC

INDUSTRY

NCT03751943 - NanoFUSE® PL Gutter PMCF | Biotech Hunter | Biotech Hunter